• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Lot Number E302-KIT
Device Problem Device Displays Incorrect Message (2591)
Patient Problems Hemorrhage/Bleeding (1888); Thrombus (2101)
Event Date 04/04/2016
Event Type  malfunction  
Manufacturer Narrative
The system was used treatment.A batch record review of kit lot e302 was conducted.There were no nonconformances associated with this lot.The lot met release requirements.The (b)(4) lot number was not provided as it was not administered.However, a review of all (b)(4) lots manufactured since january 2013 was performed.No trends or nonconformances related to the complaint were noted.Trends were reviewed for complaint categories, alarm #17: return pressure and clot observed.No trends were detected for these complaint categories.The assessment is based on information available at the time of the investigation.No product was returned for investigation; therefore, it could not be determined if the product met specification based solely on the information provided by the customer.The root cause of this issue was operator error, due to the fact that the saline and anticoagulant bags were switched.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted through the capa/continuous improvement process.(b)(4).Device not returned to manufacturer.
 
Event Description
The customer called to report an alarm #17: return pressure alarm during a single needle mode treatment procedure.The customer stated that they had pulled some clots out of the return line at about 839 ml of whole blood processed.The customer checked to ensure that the anticoagulant bag was spiked using the green line tubing, however the customer noted that the saline and anticoagulant bags were switched.The customer agreed to abort the procedure with no return of blood/products to the patient.The patient's estimated blood loss was calculated to be approximately 280ml.The customer stated that the patient was in stable condition.This is being reported only due to the malfunction as there was no adverse event reported.The customer elected not to return the kit for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS, INC
hampton NJ
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
2201 bailey ave
buffalo NY 14211
Manufacturer Contact
megan vernak
53 frontage road
hampton, NJ 08827
MDR Report Key5625769
MDR Text Key45141122
Report Number2523595-2016-00114
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Nurse
Type of Report Initial
Report Date 04/04/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Nurse
Device Expiration Date01/01/2018
Device Lot NumberE302-KIT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/04/2016
Initial Date FDA Received05/03/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-